Position in LYEL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,055,117
-$1,632,646 QoQ
Shares Held
152,299
0.0% QoQ
Ownership
0.653%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HSG Holding Ltd holds $37,256,055 across 5 Biotechnology names. LYEL ranks #4 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AVBP |
ArriVent BioPharma, Inc.
|
663,308 | $15,302,515 | |
| 2 | GPCR |
Structure Therapeutics Inc.
|
266,062 | $12,824,188 | |
| 3 | ADAG |
Adagene Inc.
|
1,343,364 | $5,265,986 | |
| 4 | LYEL |
Lyell Immunopharma, Inc.
This page
|
152,299 | $3,055,117 | |
| 5 | BRNS |
Barinthus Biotherapeutics plc.
|
1,420,473 | $808,249 |
All Filings in LYEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,055,117 | 152,299 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,687,763 | 152,299 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,473,335 | 152,299 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,346,323 | 152,299 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||